Article 1 to 2 out of 2 for "sustained-action protein therapy"
Ordered by
Medgenics appoints Vice President of Clinical Affairs (08 May 2008) will manage the Company's Phase I/II clinical trials with EPODURE, its lead sustained-actionproteintherapy to treat anaemia, which is scheduled to start mid-2008..., a stem cell therapy company. Dr. Shoshani was awarded his MD in 1978 from...
Top